All Online
Hitting Diabetes Head-on: Improving Outcomes and Reducing Therapeutic Inertia With GLP-1 Receptor Agonists: AdaptED Module 1
An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
The percentage of individuals with T2D achieving A1C <7% worsened from 2015-2018. Therapeutic inertia—failure to initiate or intensify treatment in a timely manner—is largely responsible for this problem. This program will support PCPs in overcoming therapeutic inertia through timely initiation and advancement of treatment with GLP-1 RAs and review guideline updates that support use of GLP-1 RA early in the treatment paradigm. Learners will have the opportunity to evaluate their knowledge through multiple-choice and matching questions and case-based application.
Patient Scenarios: Selecting and Implementing Digital Technology in Diabetes Care
An Interactive Case Experience
You know that insulin therapy is an important tool in improving quality of life and health outcomes for your patients with diabetes, but are you familiar with the expanding array of diabetes technology that can play an important role in improving insulin delivery and management? Do you know how to optimally use these tools? After this activity, you’ll be able to interpret continuous glucose monitoring data to improve time-in-range, minimize hypoglycemia, and reduce postprandial glycemic excursions. Don’t miss this opportunity to learn how to incorporate diabetes technology into clinical practice to optimize insulin management, bolster patients’ confidence in self-management of their diabetes, and, ultimately, improve health outcomes.
Updates From the 2021 EASD and ADA Annual Meetings on Dual GIP/GLP-1 RA Therapy: What You Should Know (Module 3)
An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
The Role of GIP and GLP-1 in the Pathophysiology of T2DM and Why it Matters (Module 2)
An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
Hitting Diabetes Head-on: Improving Outcomes and Reducing Therapeutic Inertia With GLP-1 Receptor Agonists: AdaptED Module 2
An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
The percentage of individuals with T2D achieving A1C <7% worsened from 2015-2018. Therapeutic inertia—failure to initiate or intensify treatment in a timely manner—is largely responsible for this problem. This program will support PCPs in overcoming therapeutic inertia through timely initiation and advancement of treatment with GLP-1 RAs and review guideline updates that support use of GLP-1 RA early in the treatment paradigm. Learners will have the opportunity to evaluate their knowledge through multiple-choice and matching questions and case-based application.
Advances in Diabetes and Reflections on Care
Episode 1: Coffee with Chopra
Join Dr. Sanjiv Chopra, hepatologist, author, speaker, and thought leader as he interviews his guest, Dr. Martin Abrahamson, endocrinologist and associate professor at Harvard Medical School as they discuss major advances in diabetes as well as the promise of stem cell treatment, diet and weight loss in patients with diabetes, and advances in continuous glucose monitoring. The pair will end their conversation discussing what they have learned from patients over the years.
Therapeutic Options and Shared Decision-Making
Effective Strategies for Treating Severe Hypoglycemia
Take part in this interactive case scenario that will equip you to identify which patients with diabetes need prescriptions for treatment of severe hypoglycemia, describe the currently available glucagon formulations, and pick the best option for your patient.
Addressing “Diabesity”: Weight Loss as a Key Therapeutic Goal in the Management of T2DM (Module 1)
An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
Migraine: A Patient-centered Approach to Diagnosis and Treatment
An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
How does your management of patients with migraine compare to the experts? By participating in this six-part educational initiative, which incorporates a comprehensive roundtable faculty discussion, augmented reality, and a patient narrative, you will be able to incorporate key information into your clinical practice immediately.
What PCPs Need to Know About Influenza Chemoprophylaxis (Module 3)
An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
In clinical trials, prophylactic treatment given at the start of an outbreak demonstrates a 60% to 90% reduction in the risk of developing influenza. However, identifying which patients would benefit most from influenza prophylaxis with antivirals is challenging. We’ll share with you clear guidance from the CDC to help you make the appropriate chemoprophylaxis decisions. After this short session, you’ll be able to identify patients who would be good candidates for antiviral prophylaxis and choose medications that best fit each patient. Before you see your next patient, you need to participate in this brief and innovative video-based activity that is designed to enhance learning and keep you engaged.
What’s New in Influenza Management? (Module 4)
An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
Are you aware of the recent updates in the prevention, testing, and treatment of influenza? This brief module arms you with the most important updates you’ll need to protect your patients in this upcoming influenza season. You’ll hear about the newly available quadrivalent high-dose influenza vaccine and the recently FDA-approved therapy that could potentially improve efficacy and treatment adherence while reducing transmission of influenza. You’ll also walk away with proven approaches to testing patients with acute respiratory illness—hint: it depends on what’s circulating in the community. Before you see your next patient, read through this innovative infographic that is enhanced with audio clips, questions, and additional references to enhance your learning and keep you engaged.